MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
暂无分享,去创建一个
M. Ferracin | M. Negrini | R. Vyzula | L. Radová | O. Slabý | M. Svoboda | Petra Faltejskova-Vychytilova | J. Mlčochová | I. Kiss | S. John | Barbara Zagatti | R. Němeček